据悉，本届论坛是在中国民间组织国际交流促进会指导下，由海南亚洲公益研究院联合多家机构共同举 办，来自全球16个国家和地区的政府代表、国际组织负责人、慈善家、企业家及专家学者等共600余人 汇聚博鳌，共商亚洲公益发展大计，携手应对全球可持续发展挑战，会议吸引了90余万人次在线观看直 播。 该案例集由悦尔公益、中欧国际工商学院财富管理研究中心、海南亚洲公益研究院共同编制，旨在通过 具体案例来呈现中国企业在"商业向善"上的代表性实践与前沿探索。 据介绍，健帆生物的案例聚焦二十余年"责任进化"之路，核心讲述其以血液净化技术自主创新为起点， 打破国外医疗技术垄断，通过支付端创新、基层医疗能力造血、产业链协同推动技术普惠，进而发 起"919尿毒症关爱日"构建社会共识，形成"原研创新—技术普惠—社会倡导"的商业向善闭环，诠释了 深耕医疗科技领域的民族企业以核心技术赋能社会福祉，实现"治病救人"与"产业崛起"双重使命的中国 样本。 中证报中证网讯(王珞)据健帆生物（300529）官网12月8日消息，近日，健帆生物在商业向善领域的实 践案例，被收录于《商业向善案例集2025》，并在2025亚洲公益论坛闭幕式上正式发布。 ...

Group 1 - The 2025 National Academic Forum on Severe Kidney Disease and Blood Purification Safety Quality Management was successfully held in Jinan, focusing on various aspects such as vascular access, metastatic calcification, and infection prevention in blood purification [3][5] - The forum emphasized the integration of multiple disciplines and the collaboration between academia and industry, aligning with the "Healthy China 2030" initiative [5][6] - Key discussions included the standardization of blood purification technology, the application of machine learning algorithms in quality monitoring, and innovative models in clinical demand-driven medical engineering integration [6] Group 2 - Notable experts from Japan shared insights on vascular access management and ultrasound-guided puncture techniques, highlighting Japan's advanced practices in blood dialysis [8][10] - The forum featured presentations from various leading professionals in the field, providing valuable knowledge and guidance to attendees [10][12] - The Jinan Weigao Kidney Hospital's chief expert introduced the current state of the domestic blood dialysis industry and the development of Weigao's services, which cover multiple provinces and serve nearly 10,000 patients [12]